Main Article Content

Abstract

Escherichia coli (E. coli), a major cause of male genital tract infections, is asymptomatic and may result in male infertility. We have succeeded in isolating and characterizing proteins of E. Pili coli isolates from semen of infertile men who function as adhesin with a molecular weight (MW) 32.2 kDa. This study aims to prove the ability of IgG results adhesion proteins induced pili of E. MW coli 32.2 kDa as opsonin to determine the value of the activity and phagocytic capacity and as an anti- adhesion by calculating the average number of E. coli that attached to human spermatozoa. E. coli infertile men's semen were cultured using standard bacteriology. Peritoneal macrophages were isolated from mice. Spermatozoa from donors were prepared using Sil with Select Plus. IgG was obtained from mice immunized with (1) PBS (control), (2) E. coli pili adhesion protein isolated from infertile men semen with MW of 32.2 kDa and (3) weakened E. coli isolated from infertile men's semen. Phagocytic activity value was determined by counting the number of cells activated macrophage phagocytosis process in 100 cells. Phagocytic capacity value was determined by counting the number of bacteria ingested by 25 macrophages. Anti-adhesion test was done by counting the number of bacteria attached to 100 spermatozoa. The results of this study showed difference (p=0.000) in phagocytic activity and phagocytic capacity (p=0.000) between treatment (1) and (2), and between treatment (1) to (3). However, treatment (2) and (3) did not differ neither in phagocytic activity (p=0.693) nor in phagocytosis capacity (p=0.125). Anti-adhesion test produces difference (p=0.000) in the number of E. coli that attached to human spermatozoa between treatments (1) and treatment (2), and between treatments (1) and (3). The number of E. coli that attached to human spermatozoa between treatment (2) and treatment (3) was not significantly different (p=0.371). In conclusion, IgG from the induction of E. coli pili adhesion protein of infertile men semen isolates with MW of 32.2 kDa can increase phagocytic activity and capacity as well as serve as an anti- adhesion. Thus, IgG from the induction of E. coli pili adhesion protein of infertile men semen isolates with MW of 32.2 kDa is protective against in vitro E. coli infection, so that it can be used as material to prevent male reproductive tract infections due to E. coli.

Keywords

immunoglobulin anti-adhesion opsonin E. coli spermatozoa E. coli pili adhesion protein isolated from infertile male semen with MW of 32.2 kDa

Article Details

How to Cite
Sukarjati, S., & Amilah, S. (2017). ROLE OF IMMUNOGLOBULIN G (IgG) FROM THE INDUCTION OF Escherichia coli PILI ADHESION PROTEIN ISOLATED FROM INFERTILE MALE SEMEN WITH 32.2 KDA MOLECULAR WEIGHT AS OPSONIN AND ANTI-ADHESION AN IN VITRO Escherichia coli INFECTION. Folia Medica Indonesiana, 53(2), 94–100. https://doi.org/10.20473/fmi.v53i2.6343

References

  1. Khanna J, van Look PFA, Griffin PSD (l992). A key to brighter future. Geneva, Word Organisation
  2. Salyers AA, Whitt DD (2002). Bacterial pathogenesis: A moleculer approach, Washington DC, ASM Press, p 260-268
  3. Sukarjati, Lunardhi H (200l). Pengaruh spesies bakteri dan ratio sperma/bakteri terhadap vitalitas sperma manusia secara in vitro, Jurnal Penelitian Berkala Hayati 7
  4. Sukarjati, Lunardhi H, Hinting A (2002). Pengaruh spesies bakteri dan ratio sperma/bakteri terhadap motilitas sperma manusia secara in vitro. Jurnal Pene-litian Berkala Hayati 8
  5. Sukarjati (2009). Pengaruh Staphylococcus epidermidis, Streptococcus faecalis, Enterobacter aerogenes dan Escherichia coli terhadap kerusakan membran spermatozoa. Stigma Journal of Science 03
  6. Sukarjati, Soebadi DM, Hinting A, Sujarwo (2011). Im-munogenity of 32.2 kDa Hemaglutinin MW protein of Escherichia coli isolated from infertile male's semen. Folia Medica Indonesiana 47
  7. Sukarjati, Soebadi DM, Hinting A (2013). Role of Eschericia coli Adhesin Molecule to Inhibit Escheri-chia coli Adhesion to Human Spermatozoa in Vitro, Androl Gynecol: curr Res, DOI: 104172/2327-4360